{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T22:40:58Z","timestamp":1768689658347,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"This project was supported by Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca, Rome, Italy","award":["grant no. 2004067923"],"award-info":[{"award-number":["grant no. 2004067923"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12931-016-0373-0","type":"journal-article","created":{"date-parts":[[2016,5,6]],"date-time":"2016-05-06T11:27:12Z","timestamp":1462534032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung"],"prefix":"10.1186","volume":"17","author":[{"given":"Monica","family":"Lucattelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Fineschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Selvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estrella","family":"Garcia Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Bartalesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"De Cunto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sauro","family":"Lorenzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Galeazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Lungarella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,6]]},"reference":[{"key":"373_CR1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","volume":"165","author":"American thoracic society","year":"2002","unstructured":"American thoracic society. European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2002;165:277\u2013304.","journal-title":"Am J Respir Crit Care Med"},{"key":"373_CR2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0272-5231(03)00123-0","volume":"25","author":"AH Limper","year":"2004","unstructured":"Limper AH. Chemotherapy-induced lung disease. Clin Chest Med. 2004;25:53\u201364.","journal-title":"Clin Chest Med"},{"key":"373_CR3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000079633","volume":"71","author":"P Camus","year":"2004","unstructured":"Camus P, Fanton A, Bonniaud P, Camus C, Foucher P. Interstitial lung disease induced by drugs and radiation. Respiration. 2004;71:301\u201326.","journal-title":"Respiration"},{"key":"373_CR4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/annonc\/mdj057","volume":"17","author":"I Dimopoulou","year":"2006","unstructured":"Dimopoulou I, Bamias A, Lyberopoulos P, Dimopoulos MA. Pulmonary toxicity from novel antineoplastic agents. Ann Oncol. 2006;17:372\u20139.","journal-title":"Ann Oncol"},{"key":"373_CR5","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1440-1843.2009.01624.x","volume":"14","author":"RM Kottmann","year":"2009","unstructured":"Kottmann RM, Hogan CM, Phipps RP, Sime PJ. Determinants of initiation and progression of idiopathic pulmonary fibrosis. Respirology. 2009;14:917\u201333.","journal-title":"Respirology"},{"key":"373_CR6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2165\/11591490-000000000-00000","volume":"71","author":"Q Ding","year":"2011","unstructured":"Ding Q, Luckhardt T, Hecker L, Zhou Y, Liu G, Antony VB, et al. New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis. Drugs. 2011;71:981\u20131001.","journal-title":"Drugs"},{"key":"373_CR7","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s12325-011-0066-5","volume":"28","author":"OJ O\u2019Connell","year":"2011","unstructured":"O\u2019Connell OJ. Idiopathic pulmonary fibrosis:treatment update. Adv Ther. 2011;28:989\u201399.","journal-title":"Adv Ther"},{"key":"373_CR8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrc1547","volume":"5","author":"J Chen","year":"2005","unstructured":"Chen J, Stubbe J. Bleomycins: towards better therapeutics. Nat Rev Cancer. 2005;5:102\u201312.","journal-title":"Nat Rev Cancer"},{"key":"373_CR9","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S1052-3359(02)00029-7","volume":"12","author":"LH Einhorn","year":"2002","unstructured":"Einhorn LH. Chemotherapeutic and surgical strategies for germ cell tumors. Chest Surg Clin N Am. 2002;12:695\u2013706.","journal-title":"Chest Surg Clin N Am"},{"key":"373_CR10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1021\/np990549f","volume":"63","author":"SM Hecht","year":"2000","unstructured":"Hecht SM. Bleomycin: new perspectives on the mechanism of action. J Nat Prod. 2000;63:158\u201368.","journal-title":"J Nat Prod"},{"key":"373_CR11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1378\/chest.120.2.617","volume":"120","author":"S Sleijfer","year":"2001","unstructured":"Sleijfer S. Bleomycin-induced pneumonitis. Chest. 2001;120:617\u201324.","journal-title":"Chest"},{"key":"373_CR12","first-page":"170","volume":"112","author":"DB Chandler","year":"1983","unstructured":"Chandler DB, Hyde DM, Giri SN. Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters. Am J Pathol. 1983;112:170\u20137.","journal-title":"Am J Pathol"},{"key":"373_CR13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/path.2119","volume":"211","author":"B Hu","year":"2007","unstructured":"Hu B, Ullenbruch MR, Jin H, Gharaee-Kermani M, Phan SH. An essential role for CCAAT\/enhancer binding protein beta in bleomycin-induced pulmonary fibrosis. J Pathol. 2007;211:455\u201362.","journal-title":"J Pathol"},{"key":"373_CR14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1164\/ajrccm\/141.3.765","volume":"14","author":"J Kelley","year":"1990","unstructured":"Kelley J. Cytokines of the lung. Am Rev Respir Dis. 1990;14:765\u201388.","journal-title":"Am Rev Respir Dis"},{"key":"373_CR15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.drudis.2015.01.001","volume":"20","author":"P Spagnolo","year":"2015","unstructured":"Spagnolo P, Wells AU, Collard HR. Pharmacological treatment of idiopathic pulmonary fibrosis: an update. Drug Discov Today. 2015;20:514\u201324.","journal-title":"Drug Discov Today"},{"key":"373_CR16","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/ard.2010.137539","volume":"70","author":"E Balistreri","year":"2011","unstructured":"Balistreri E, Garcia-Gonzalez E, Selvi E, Akhmetshina A, Palumbo K, Lorenzini S, et al. The cannabinoid WIN55, 212\u20132 abrogates dermal fibrosis in scleroderma bleomycin model. Ann Rheum Dis. 2011;70:695\u20139.","journal-title":"Ann Rheum Dis"},{"key":"373_CR17","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/annrheumdis-2011-200314","volume":"71","author":"E Garcia-Gonzalez","year":"2012","unstructured":"Garcia-Gonzalez E, Balistreri E, Selvi E, Balistreri E, Akhmetshina A, Palumbo K, et al. Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis. Ann Rheum Dis. 2012;71:1545\u201351.","journal-title":"Ann Rheum Dis"},{"key":"373_CR18","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1183\/09031936.01.17304740","volume":"17","author":"E Cavarra","year":"2001","unstructured":"Cavarra E, Martorana PA, Bartalesi B, Fineschi S, Gambelli F, Lucattelli M, et al. Genetic deficiency of alpha1-PI in mice influences lung responses to bleomycin. Eur Respir J. 2001;17:474\u201380.","journal-title":"Eur Respir J"},{"key":"373_CR19","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1165\/rcmb.2007-0386OC","volume":"41","author":"L Atzori","year":"2009","unstructured":"Atzori L, Lucattelli M, Scotton CJ, Laurent GJ, Bartalesi B, De Cunto G, et al. Absence of proteinase-activated receptor-1 signaling in mice confers protection from fMLP-induced goblet cell metaplasia. Am J Respir Cell Mol Biol. 2009;41:680\u20137.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"373_CR20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jcp.41.4.467","volume":"41","author":"T Ashcroft","year":"1988","unstructured":"Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol. 1988;41:467\u201370.","journal-title":"J Clin Pathol"},{"key":"373_CR21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1053\/j.gastro.2005.05.019","volume":"129","author":"AL Theiss","year":"2005","unstructured":"Theiss AL, Fuller CR, Simmons JG, Liu B, Sartor RB, Lund PK. Growth hormone reduces the severity of fibrosis associated with chronic intestinal inflammation. Gastroenterology. 2005;129:204\u201319.","journal-title":"Gastroenterology"},{"key":"373_CR22","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2353\/ajpath.2010.091107","volume":"177","author":"K Borensztajn","year":"2010","unstructured":"Borensztajn K, Bresser P, van der Loos C, Bot I, van den Blink B, den Bakker MA, et al. Protease-activated receptor-2 induces myofibroblast differentiation and tissue factor Up-regulation during bleomycin-induced lung injury. Am J Pathol. 2010;177:2753\u201364.","journal-title":"Am J Pathol"},{"key":"373_CR23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0003-2697(67)90160-1","volume":"19","author":"KI Kivirikko","year":"1967","unstructured":"Kivirikko KI, Laitinen O, Prockop DJ. Modification of a specific assay for hydroxyproline in urine. Anal Biochem. 1967;19:249\u201355.","journal-title":"Anal Biochem"},{"key":"373_CR24","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S1357-2725(02)00015-8","volume":"34","author":"F Cocci","year":"2002","unstructured":"Cocci F, Miniati M, Monti S, Cavarra E, Gambelli F, Battolla L, et al. Urinary desmosine excretion is inversely correlated with the extent of emphysema in patients with chronic obstructive pulmonary disease. Int J Biochem Cell Biol. 2002;34:594\u2013604.","journal-title":"Int J Biochem Cell Biol"},{"key":"373_CR25","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.biocel.2007.08.011","volume":"40","author":"A Moeller","year":"2008","unstructured":"Moeller A, Ask K, Warburton D, Gauldie J, Kolb M. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol. 2008;40:362\u201382.","journal-title":"Int J Biochem Cell Biol"},{"key":"373_CR26","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1164\/rccm.200505-717OC","volume":"173","author":"NI Chaudhary","year":"2006","unstructured":"Chaudhary NI, Schnapp A, Park JE. Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. Am J Respir Crit Care Med. 2006;173:769\u201376.","journal-title":"Am J Respir Crit Care Med"},{"key":"373_CR27","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.neuropharm.2005.02.010","volume":"48","author":"K Salim","year":"2005","unstructured":"Salim K, Schneider U, Burstein S, Hoy L, Karst M. Pain measurements and side effect profile of the novel cannabinoid ajulemic acid. Neuropharmacology. 2005;48:1164\u201371.","journal-title":"Neuropharmacology"},{"key":"373_CR28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/BOR.0b013e32833de1a7","volume":"22","author":"J Wei","year":"2010","unstructured":"Wei J, Bhattacharyya S, Varga J. Peroxisome proliferator-activated receptor \u03b3: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosis. Curr Opin Rheumatol. 2010;22:671\u20136.","journal-title":"Curr Opin Rheumatol"},{"key":"373_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2007\/71323","volume":"2007","author":"HF Lakatos","year":"2007","unstructured":"Lakatos HF, Thatcher TH, Kottmann RM, Garcia TM, Phipps RP, Sime PJ. The role of PPARs in lung fibrosis. PPAR Res. 2007;2007:1\u201310.","journal-title":"PPAR Res"},{"key":"373_CR30","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1124\/mol.63.5.983","volume":"63","author":"J Liu","year":"2003","unstructured":"Liu J, Li H, Burstein SH, Zurier RB, Chen JD. Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid. Mol Pharmacol. 2003;63:983\u201392.","journal-title":"Mol Pharmacol"},{"key":"373_CR31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4419-9072-3_22","volume":"544","author":"W Berghe Vanden","year":"2003","unstructured":"Vanden Berghe W, Vermeulen L, Delerive P, De Bosscher K, Staels B, Haegeman G. A paradigm for gene regulation: inflammation, NF-kappaB and PPAR. Adv Exp Med Biol. 2003;544:181\u201396.","journal-title":"Adv Exp Med Biol"},{"key":"373_CR32","doi-asserted-by":"crossref","first-page":"32681","DOI":"10.1074\/jbc.M002577200","volume":"276","author":"SW Chung","year":"2000","unstructured":"Chung SW, Kang BY, Kim SH, Kim YM, Cho D, Trinchieri G, et al. Oxidized low density lipoprotein inhibits interleukin- 12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between PPAR\u03b3 and NF- kappaB B. J Biol Chem. 2000;276:32681\u20137.","journal-title":"J Biol Chem"},{"key":"373_CR33","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.imbio.2009.09.007","volume":"215","author":"SE O'Sullivan","year":"2010","unstructured":"O'Sullivan SE, Kendall DA. Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease. Immunobiology. 2010;215:611\u20136.","journal-title":"Immunobiology"},{"key":"373_CR34","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00011-005-1379-0","volume":"54","author":"D Liu","year":"2005","unstructured":"Liu D, Zeng BX, Zhang SH, Yao SL. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia. Inflamm Res. 2005;54:464\u201370.","journal-title":"Inflamm Res"},{"key":"373_CR35","first-page":"152","volume":"134","author":"MG Belvisi","year":"2008","unstructured":"Belvisi MG, Hele DJ. Peroxisome proliferator-activated receptors as novel targets in lung disease. Chest. 2008;134:152\u20137.","journal-title":"Chest"},{"key":"373_CR36","first-page":"235","volume":"32","author":"H Uto","year":"2005","unstructured":"Uto H, Nakanishi C, Ido A, Hasuike S, Kusumoto K, Abe H, et al. The peroxisome proliferator-activated receptor-gamma agonist, pioglitazone, inhibits fat accumulation and fibrosis in the livers of rats fed a choline-deficient, l-amino acid-defined diet. Hepatol Res. 2005;32:235\u201342.","journal-title":"Hepatol Res"},{"key":"373_CR37","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1093\/ndt\/gfl212","volume":"21","author":"AC Calkin","year":"2006","unstructured":"Calkin AC, Giunti S, Jandeleit-Dahm KA, Allen TJ, Cooper ME, Thomas MC. PPAR-alpha and -gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse. Nephrol Dial Transplant. 2006;21:2399\u2013405.","journal-title":"Nephrol Dial Transplant"},{"key":"373_CR38","doi-asserted-by":"crossref","first-page":"L891","DOI":"10.1152\/ajplung.00333.2007","volume":"294","author":"JE Milam","year":"2008","unstructured":"Milam JE, Keshamouni VG, Phan SH, Hu B, Gangireddy SR, Hogaboam CM, et al. PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2008;294:L891\u2013901.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"373_CR39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000168676","volume":"77","author":"Y Aoki","year":"2009","unstructured":"Aoki Y, Maeno T, Aoyagi K, Ueno M, Aoki F, Aoki N, et al. Pioglitazone, a peroxisome proliferator-activated receptor gamma ligand, suppresses bleomycin-induced acute lung injury and fibrosis. Respiration. 2009;77:311\u20139.","journal-title":"Respiration"},{"key":"373_CR40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1183\/09031936.05.00049704","volume":"25","author":"T Genovese","year":"2005","unstructured":"Genovese T, Cuzzocrea S, Di Paola R, Mazzon E, Mastruzzo C, Catalano P, et al. Effect of rosiglitazone and 15-deoxy-Delta12, 14-prostaglandin J2 on bleomycin-induced lung injury. Eur Respir J. 2005;25:225\u201334.","journal-title":"Eur Respir J"},{"key":"373_CR41","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/sj.bjp.0707423","volume":"152","author":"SE O'Sullivan","year":"2007","unstructured":"O'Sullivan SE. Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. Br J Pharmacol. 2007;152:576\u201382.","journal-title":"Br J Pharmacol"},{"key":"373_CR42","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/thoraxjnl-2011-200717","volume":"67","author":"GM Mutlu","year":"2012","unstructured":"Mutlu GM, Budinger GR, Wu M, Lam AP, Zirk A, Rivera S, et al. Proteasomal inhibition after injury prevents fibrosis by modulating TGF-\u03b2 (1) signalling. Thorax. 2012;67:139\u201346.","journal-title":"Thorax"},{"key":"373_CR43","doi-asserted-by":"crossref","first-page":"9856","DOI":"10.1073\/pnas.92.21.9856","volume":"92","author":"E Hu","year":"1995","unstructured":"Hu E, Tontonoz P, Spiegelman BM. Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR\u03b3 and C\/EBP\u03b1. Proc Natl Acad Sci U S A. 1995;92:9856\u201360.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"373_CR44","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cbpa.2010.04.003","volume":"156","author":"S Liu","year":"2010","unstructured":"Liu S, Wang Y, Wang L, Wang N, Li Y, Li H. Transdifferentiation of fibroblasts into adipocyte-like cells by chicken adipogenic transcription factors. Comp Biochem Physiol A Mol Integr Physiol. 2010;156:502\u20138.","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"key":"373_CR45","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/MAJ.0b013e31821aa000","volume":"241","author":"AL Degryse","year":"2011","unstructured":"Degryse AL, Lawson WE. Progress toward improving animal models for idiopathic pulmonary fibrosis. Am J Med Sci. 2011;241:444\u20139.","journal-title":"Am J Med Sci"},{"key":"373_CR46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1165\/rcmb.2013-0094TR","volume":"49","author":"B Moore","year":"2013","unstructured":"Moore B, Lawson WE, Oury TD, Sisson TH, Raghavendran K, Hogaboam CM. Animal Models of Fibrotic Lung Disease. Am J Respir Cell Mol Biol. 2013;49:167\u201379.","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-016-0373-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T12:53:12Z","timestamp":1498308792000},"score":1,"resource":{"primary":{"URL":"http:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-016-0373-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,6]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["373"],"URL":"https:\/\/doi.org\/10.1186\/s12931-016-0373-0","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,6]]},"article-number":"49"}}